Apple-Samsung Patent Ruling, Bristol-Myers Drug

Apple-Samsung Patent Ruling, Bristol-Myers Drug Play

Aug. 24 (Bloomberg) -- In today's "Bloomberg Equities Report," Bloomberg's Deirdre Bolton reports that a South Korean court has ruled against both Apple and Samsung in their patent dispute, Salesforce.com falls short of profit estimates and Bristol-Meyers has dropped an experimental hepatitis C drug after a patient's death. She speaks on Bloomberg Television's "In The Loop."

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus